Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Richard Reichl is active.

Publication


Featured researches published by Richard Reichl.


European Journal of Pharmacology | 1980

Inhibition of neurosympathetic cerebroarterial constriction by clonidine in cats

Richard Reichl; Alexander Walland

In cats anaesthetized with chloralose the cervical sympathetic nerves were separated from the vagosympathetic trunk and severed. Bilateral preganglionic electrical stimulation of the efferent sympathetic stumps induced rate-dependent decrements in cerebrospinal fluid pressure measured in the cerebral lateral ventricle. Intravenous injection of 3, 10, and 30 micrograms/kg clonidine caused a dose-related shift in threshold and inhibition of the pressure decrease particularly at lower rates of stimulation. Intravenous infusion of 3.75 micrograms/kg . min yohimbine for 30 min reduced the inhibitory effect of 30 micrograms/kg clonidine i.v. Intravenous injection of 5 mg/kg phentolamine reduced the depressor effect at all rates of electrical sympathetic stimulation. In another group of cats craniotomy was performed and the diameter of pial arteries (0.1-0.2 mm) was measured with an eyepiece micrometer under the microscope. Bilateral electrical stimulation of the sympathetic nerves decreased the artery diameter by 16%. This effect was diminished by 30 micrograms/kg clonidine i.v. Because of the characteristic shift of the frequency-response curve caused by clonidine and the antagonistic effect of yohimbine it is assumed that clonidine inhibits sympathetic neurotransmission in pial arteries by activation of prejunctional alpha-adrenoceptors. The inhibitory effect of clonidine in neurosympathetic transmission might explain the efficacy of the drug in the treatment of migraine.


Archive | 1990

Thienylcarboxylic acid ester of aminoalcohols, their quaternary products, their preparation and use of the compounds

Rolf Banholzer; Rudolf Bauer; Richard Reichl


Life Sciences | 1993

Ba 679 Br, a novel long-acting anticholinergic bronchodilator

Bernd Disse; Richard Reichl; Georg Speck; Werner Traunecker; Karl Ludwig Rominger; Rudolf Hammer


Archive | 2005

Esters of thienyl carboxylic acids and amino alcohols and their quaternization products

Rolf Banholzer; Rudolf Bauer; Richard Reichl


Archive | 2001

Pharmaceutical compositions based on anticholinergics and corticosteroids

Michel Pairet; Michael P. Pieper; Christopher John Montague Meade; Richard Reichl; Christel Schmelzer


Archive | 2000

Medicament compositions based on anticholinergically-effective compounds and beta-mimetics

Karl-Heinz Bozung; Michel Pairet; Richard Reichl; Alexander Walland


Archive | 1995

Esters of bi- and tricyclic amino alcohols and their use in pharmaceutical compositions

Rolf Banholzer; Rudolf Bauer; Richard Reichl


Archive | 2001

Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Helmut Meissner; Gerd Morschhäuser; Michael P. Pieper; Gerald Pohl; Richard Reichl; Georg Speck; Rolf Banholzer


Archive | 2000

Medicament compositions based on tiotropium bromide and formoterol fumarate

Karl-Heinz Bozung; Michel Pairet; Richard Reichl; Alexander Walland


Archive | 2001

Anticholinergics which may be used as medicaments as well as processes for preparing them

Helmut Meissner; Gerd Morschhaeuser; Michael P. Pieper; Gerald Pohl; Richard Reichl; Georg Speck; Rolf Banholzer

Collaboration


Dive into the Richard Reichl's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge